Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis

Multiple Sclerosis Journal

Volumn 20, Issue 13, 2014, Pages 1699-1703

  Nerrant, Elodie ^b   Salsac, Céline ^c   Charif, Mahmoud ^b   Ayrignac, Xavier ^b   Carra Dalliere, Clarisse ^b   Castelnovo, Giovanni ^d   Goulabchand, Radjiv ^b   Tisseyre, Julie ^a   Raoul, Cédric ^c   Eliaou, Jean François ^a   Labauge, Pierre ^b   Vincent, Thierry ^a,c  

^a HÔPITAL SAINT ELOI   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c Montpellier University Medical Center   (France)

^d NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

Biomarker; Diagnosis; ELISA; Kir4.1 antibody; Multiple sclerosis

Indexed keywords

AUTOANTIBODY; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR4.1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FINGOLIMOD; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; NATALIZUMAB; PROTEIN KIR4.1; AUTOANTIGEN; KCNJ10 (CHANNEL);

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEMALINE MYOPATHY; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; IMMUNOFLUORESCENCE TEST; NEUROLOGIC DISEASE; PREVALENCE; RELIABILITY; VERY ELDERLY; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MULTIPLE SCLEROSIS; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 84908141883     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514531086     Document Type: Article

References (8)

1. Berger T, Rubner P, Schautzer F et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003; 349(2): 139-45.
2. Srivastava R, Aslam M, Kalluri SR et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012; 367(2): 115-23.
3. Kraus V, Srivastava R, Kalluri SR et al. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease. Neurology 2014; 82(6): 470-3.
4. Polman CH, Reingold SC, Banwell B et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292-302.
5. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364(9451): 2106-12.
6. Masaki H, Wakayama Y, Hara H et al. Immunocytochemical studies of aquaporin 4, Kir4.1, and alpha1-syntrophin in the astrocyte endfeet of mouse brain capillaries. Acta Histochem Cytochem 2010; 43(4): 99-105.
7. Higashimori H and Sontheimer H. Role of Kir4.1 channels in growth control of glia. Glia 2007; 55(16): 1668-79.
8. Neusch C, Rozengurt N, Jacobs RE et al. Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci 2001; 21(15): 5429-38.